![Neil McFarlane](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Neil McFarlane
Chief Executive Officer at
ZEVRA THERAPEUTICS, INC.
Net worth: 4 M $ as of 2026-05-30
Profile
Neil F.
McFarlane is President, Chief Executive Officer & Director at Zevra Therapeutics, Inc. since 2023.
Former roles include Chief Executive Officer at Adamas Pharmaceuticals LLC from 2019 to 2021, Independent Director at Collegium Pharmaceutical, Inc. from 2022 to 2024, Vice President & General Manager at UCB, Inc. from 2011 to 2016, and Chief Operating Officer at Travere Therapeutics, Inc. from 2016 to 2019.
Education includes undergraduate and graduate degrees from the University of Florida.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-05 | 304,282 ( 0.51% ) | 4 M $ | 2026-05-30 |
Neil McFarlane active positions
| Companies | Position | Start |
|---|---|---|
| ZEVRA THERAPEUTICS, INC. | Chief Executive Officer | 2023-10-09 |
Former positions of Neil McFarlane
| Companies | Position | End |
|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INC. | Director/Board Member | 2024-07-27 |
| ADAMAS PHARMACEUTICALS, INC. | Chief Executive Officer | 2021-10-31 |
| TRAVERE THERAPEUTICS, INC. | Chief Operating Officer | 2019-05-30 |
UCB, Inc.
 UCB, Inc. Financial ConglomeratesFinance Provides financial services | Corporate Officer/Principal | 2015-12-31 |
Training of Neil McFarlane
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
20
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Collegium Pharmaceutical, Inc.
 Collegium Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Adamas Pharmaceuticals LLC
 Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets therapeutics for neurological diseases | Health Technology |
Zevra Therapeutics, Inc.
 Zevra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets proprietary prodrugs | Health Technology |
University of Florida
 University of Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UCB, Inc.
UCB, Inc. Financial ConglomeratesFinance Provides financial services | Finance |
Travere Therapeutics, Inc.
 Travere Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in developing and delivering life-changing therapies to people living with rare kidney, liver & metabolic diseases | Health Technology |
- Stock Market
- Insiders
- Neil McFarlane
